Pharmala Biotech Holdings Inc

OTCQB:MDXXF USA Biotechnology

Market Cap

$12.75 Million

Market Cap Rank

#29051 Global

#9644 in USA

Share Price

$0.12

Change (1 day)

+3.63%

52-Week Range

$0.11 - $0.16

All Time High

$0.54

Pharmala Biotech Holdings Inc - Asset Resilience Ratio

Latest as of November 2025: 22.76%

Pharmala Biotech Holdings Inc (MDXXF) has an Asset Resilience Ratio of 22.76% as of November 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$773.53K

Cash + Short-term Investments

Total Assets

$3.40 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2025)

This chart shows how Pharmala Biotech Holdings Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Pharmala Biotech Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$773.53K	22.76%
Total Liquid Assets	$773.53K	22.76%

Asset Resilience Insights

Good Liquidity Position: Pharmala Biotech Holdings Inc maintains a healthy 22.76% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.